Abstract:Objective: We aimed to explore the feasibility of a novel apoptosis imaging agent (99)mTc-DCD, and to study the uptake of apoptotic cells in vitro and the distribution characteristics in normal Kunming mice. Methods: CBT-DEVD was dissolved in 2% DMSO, and DTPAA was added to make DTPA-CBT-DEVD (DCD) at room temperature for 30 minutes. Isolation and purification were performed by High Performance Liquid Chromatography (HPLC) purification. Moreover, mass spectrometer and ultraviolet spectrum were used to verify the chemical molecular structure. (99)mTc-DCD was made in combination with SnCl2 by direct labeling method and was used to detect the radiochemical purity and stability in vitro. The fresh prepared caspase-3 work buffe, 5U caspase-3 enzyme solution and 10 mu Ci(99)mTc-DCD solution were successively added, and mixed fully in the test tube. After 2 hours the reaction, the nanoparticles formed by copper mesh were observed by fluoroscopy. In addition, no caspase-3 was added in the control group. Subsequently. the supernatant was discarded and the radioactive count was measured. Besides, (99)mTc-DCD was added to the normal and cisplatin induced apoptotic Hela cell culture medium to observe the cell uptake in vitro. Each healthy Kunming mouse was injected with 0.2mCi(99)mTc-DCD from the tail vein, to perform SPECT imaging and study their biological distribution. Results: DCD was made after mixing with CBT-DEVD and DTPAA for 30 minutes, and its molecular weight was 1,370 g/mol by mass spectrometry. According to direct labeling method, the labeling rate of (99)mTc-DCD was 96%. After left 30 minutes and 120 minutes in fresh human serum, radiochemical purity was 91.5% and 90.8%, respectively. Besides, radiochemical purity was 90.0% after left 5 hours in normal saline and serum. (99)mTc-DCD reacted with caspase-3 enzyme for 2 hours in vitro, and transmission electron microscope showed that nanoparticles with an average diameter of about 500 nm formed. The radioactivity count of precipitation in the test tube was significantly about 3.1 times higher than that of the control tube. The cell uptake rate of (99)mTc-DCD in the apoptotic model of Hela cells was significantly higher than that in normal Hela cells (P < 0.01). In addition, cisplatin induced apoptosis of Hela cells was positive in term of caspase-3 expression. The biological distribution of (99)mTc-DCD in normal Kunming mice showed that the blood clearance rate of (99)mTc-DCD was faster and mainly excreted by the kidneys. Conclusion: (99)mTc-DCD, an apoptotic probe made by direct labeling method, could be self-assembled into nanoparticles after caspase-3 recognition and shearing, thus enriching the apoptotic cells and playing the role of signal amplification. In addition, (99)mTc-DCD labeled method was simple and convenient with high labeling rate, good stability and ideal cell uptake in vitro. The imaging in mice showed that it was mainly excreted through the kidneys. Therefore, (99)mTc-DCD was a potential imaging agent for apoptosis, which was expected to be used to evaluate the efficacy of radiotherapy and chemotherapy, and to detect the apoptotic state of ischemic tissues. Besides, further studies were performed to confirm its effect of clinical application.

Structure-inherent Near-Infrared Fluorescent Probe Mediates Apoptosis Imaging and Targeted Drug Delivery in Vivo

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

A Near-Infrared Multifunctional Fluorescent Probe With An Inherent Tumor-Targeting Property For Bioimaging

Triarylboron-Based High Photosensitive Probes for Apoptosis Detection, Tumor-Targeted Imaging, and Selectively Inducing Apoptosis of Tumor Cells by Photodynamics

Design of "smart" Probes for Optical Imaging of Apoptosis

A Fluorescent Turn on Nanoprobe for Simultaneous Visualization of Dual-Targets Involved in Cell Apoptosis and Drug Screening in Living Cells

Design, Synthesis, and Biological Evaluation of 4-(5-dimethylamino-naphthalene-1-sulfon-amido)-3-(4-iodophenyl)butanoic Acid As a Novel Molecular Probe for Apoptosis Imaging

Selective Imaging and Cancer Cell Death Via Ph Switchable Near-Infrared Fluorescence and Photothermal Effects.

Azo-based near-infrared fluorescent theranostic probe for tracking hypoxia-activated cancer chemotherapy in vivo.

Apoferritin-Engineered Nanoprobe for Tumor-Targeted Triple-NIR Imaging and Phototherapy

Synthesis And Imaging Of An Apoptotic Probe (99)Mtc-Dtpa-Cbt-Devd With Caspase-3 Controlled Self-Assembly Of Nanoparticles

Multi-armed tetrahedral DNA probes for visualizing the whole-course of cell apoptosis by simultaneously fluorescence imaging intracellular cytochrome c and telomerase

A tumor-targeting probe based on a mitophagy process for live imaging.

Near-infrared Fluorescent Probes in Cancer Imaging and Therapy: an Emerging Field

A Tumor-targetable NIR Probe with Photoaffinity Crosslinking Characteristics for Enhanced Imaging-Guided Cancer Phototherapy

Indocyanine Green-Containing Nanostructure As Near Infrared Dual-Functional Targeting Probes for Optical Imaging and Photothermal Therapy

Evaluating Visually A New Apoptosis-Induced Reagent By A Ratiometric Two-Photon Fluorescent Ph Probe

Bioluminescence and Photoacoustic Dual-Modality Imaging of Apoptosis Using a Duramycin-Immobilized Gold Nanorod Probe

Multifunctional Gold Nanoparticle-Based Fluorescence Resonance Energy-Transfer Probe for Target Drug Delivery and Cell Fluorescence Imaging.

A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis

Unique pH-Sensitive RNA Binder for Ratiometric Visualization of Cell Apoptosis.